| |
| |
|
| Insider
Information: |
Roberts Eiry |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
67,730 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,779,165 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
67,730 |
|
|
| Total
Value |
$3,779,165 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neurocrine Biosciences Inc |
NBIX |
Chief Medical Officer |
2024-02-13 |
23,716 |
2019-01-08 |
0 |
Premium* |
|
|
Amicus Therapeutics Inc |
FOLD |
Director |
2023-06-08 |
44,014 |
2021-06-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
35 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2021-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
22,759 |
22,759 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2022-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
12,671 |
35,430 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2023-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
8,584 |
44,014 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2023-12-08 |
4 |
OE |
$81.05 |
$24,315 |
D/D |
300 |
29,621 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2023-12-08 |
4 |
AS |
$120.00 |
$36,031 |
D/D |
(300) |
29,521 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2022-02-08 |
4 |
AS |
$79.52 |
$77,931 |
D/D |
(980) |
24,625 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2023-02-08 |
4 |
AS |
$104.16 |
$102,072 |
D/D |
(980) |
41,015 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2023-02-06 |
4 |
AS |
$105.80 |
$118,602 |
D/D |
(1,121) |
27,176 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2024-02-08 |
4 |
AS |
$134.21 |
$131,522 |
D/D |
(980) |
22,717 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2024-02-13 |
4 |
AS |
$132.96 |
$148,122 |
D/D |
(1,114) |
23,716 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2019-01-08 |
4 |
AS |
$84.09 |
$156,159 |
D/D |
(1,857) |
3,143 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2024-02-06 |
4 |
AS |
$142.24 |
$159,446 |
D/D |
(1,121) |
21,837 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2023-01-31 |
4 |
AS |
$109.99 |
$160,254 |
D/D |
(1,457) |
26,171 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2020-02-07 |
4 |
AS |
$103.31 |
$167,675 |
D/D |
(1,623) |
7,452 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2020-04-24 |
4 |
AS |
$99.47 |
$192,376 |
D/D |
(1,934) |
9,416 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2022-01-10 |
4 |
AS |
$74.50 |
$196,088 |
D/D |
(2,632) |
21,279 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2020-11-12 |
4 |
AS |
$90.74 |
$204,810 |
D/D |
(2,257) |
13,477 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2024-01-31 |
4 |
AS |
$140.79 |
$205,132 |
D/D |
(1,457) |
20,832 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2022-02-07 |
4 |
AS |
$80.77 |
$221,660 |
D/D |
(2,744) |
23,746 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2020-08-05 |
4 |
AS |
$118.84 |
$268,225 |
D/D |
(2,257) |
11,446 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2021-02-08 |
4 |
AS |
$116.67 |
$275,944 |
D/D |
(2,363) |
18,693 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2021-01-08 |
4 |
AS |
$111.06 |
$292,297 |
D/D |
(2,632) |
15,845 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2020-01-08 |
4 |
AS |
$111.11 |
$292,445 |
D/D |
(2,632) |
5,991 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2023-08-21 |
4 |
AS |
$107.38 |
$343,388 |
D/D |
(3,198) |
29,521 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2020-06-23 |
4 |
OE |
$77.81 |
$389,050 |
D/D |
5,000 |
14,416 |
0 |
- |
|
35 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
